Abstract
The aim of this study was to determine if a relationship exists between nonalcoholic steatohepatitis (NASH) and serum levels of free fatty acids, choline deficiency, or celiac disease. Forty-seven patients with liver biopsy proven NASH were enrolled. Total serum free fatty acids and anti-endomysial antibodies were determined in all patients, while plasma free and phospholipid-bound choline were determined in 29 patients. Total serum free fatty acid concentration correlated significantly with female gender and serum albumin concentration. Patients with severe fibrosis on liver biopsy had significantly greater serum concentration of free fatty acids than patients without severe fibrosis. Plasma free and phospholipid-bound choline levels were normal and no significant correlation was found between the concentration of plasma free or phospholipid bound choline, and the severity of liver damage. Only one of the 47 patients with NASH had a positive titer for the anti-endomysial antibody. In conclusion, increased serum concentrations of free fatty acids were found in NASH and were associated with development of more severe liver disease. Neither choline deficiency nor celiac sprue by anti-endomysial antibody testing was associated with NASH.
Article PDF
Similar content being viewed by others
REFERENCES
Angulo P, Lindor KD: Management of nonalcoholic steatohepatitis. In Medical Management of Liver Disease. ED Kravitt (ed.) New York, Marcel Dekker, 1999; pp 367–380.
Falchuck KR, Fiske SC, Haggit, RC, Federman, M., Trey C: Pericentral hepatic fibrosis and intracellular hyalin in diabetic patients. Gastroenterology 78:535–541, 1980
Diehl AM, Goodman Z, Ishak KG: Alcohol like liver disease in non-alcoholic. A clinical and histological comparison with alcohol induced liver disease. Gastroenterology 95:1056–1062, 1988
Powell EE, Cooksley GE, Hanson R, Searle J, Halliday JW, Powell LW: The natural history of Nonalcoholic steatohepatitis: A follow-up study of forty-two patients for up to 21 years. Hepatology 11:74–80, 1990
Adler M, Schaffner F: Fatty liver hepatitis and cirrhosis in obese patients. Am J Med 67:811–816, 1979
Itoh S, Yougel T, Kawagoe K: Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis. Am J Gastroenterol 82:650–654, 1987
Alpers DH, Sabesin SM, White HM: Fatty liver biochemical and clinical aspects. In Diseases of the Liver, Vol II. L Schiff, ER Schiff (eds). Philadelphia, JB Lippincott Company, 1993; pp 825–855
Buchman AL, Moukarzel AA, Jenden DJ, Roch M, Rice K, Ament ME: Low plasma free choline is prevalent in patients receiving long term parenteral nutrition and is associated with hepatic aminotransferase abnormalities. Clin Nutr 12:33–37, 1993
Vairo P, Fontanello A, Mayer M, DeVincenzo A, Terricciano LM, D'Armiento M, Vecchione R: Elevated serum aminotransferase activity as an early manifestation of gluten sensitive enteropathy. J Pediatr 122:416–419, 1993
Hay JE, Wiesner RH, Shorter RG, LaRusso NF, Baldus WP: Primary sclerosing cholangitis and celiac disease: A novel association. Ann Intern Med 109:713–717, 1988
Lynch DA, Thornton JR, Axon AT: Acute fatty liver complicating coeliac disease. Eur J Gastroenterol Hepatol 6:745–747, 1994
Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR: Nonalcoholic steatohepatitis: a proposal for grading and stating the histological lesions. Am J Gastroenterol 94:2467–2474, 1999
Fajans S. Classification and diagnosis of diabetes. In Diabetes Mellitus: Theory and Practice, 4th ed. H Rifkin, D Porte (eds). New York; Elsevier, 1990, pp 346–356
Mahley RW, Weisgraber KH, Farese RV Jr: Disorders of lipid metabolism. In Endocrinology, 9th Ed. JD Wilson, DW Foster, HM Kronenber, PR Larsen (eds). Philadelphia, WB Saunders, Company. 1998; pp 1099–1154
Bray GA: Pathophysiology of obesity. Am J Clin Nutr 55(suppl):488S–494S, 1992
Murray JA: Serodiagnosis of celiac disease. Clin Lab Med 17:445–464, 1997
Freeman JJ, Choi RL, Jenden DJ: Plasma choline: Its turnover and exchange with brain choline. J Neurochem 24:729–734, 1975
Jenden DJ, Roch M, Booth RA: Simultaneous measurement of endogenous and deuterium-labeled tracer variants of choline and acetylcholine in subpicomole quantities by gas chromatography spectrometry. Anal Biochem 55:438–448, 1973
Folch J, Lees M, Stanley GHS: Simple method for the isolation and purification of total lipids from animal tissue. J Biol Chem 226:497–509, 1957
Jope RS, Jenden DJ: Choline and phospholipid metabolism and the synthesis of acetylcholine in rat brain. J Neurosci Res 4:69–82, 1979
Catassi C, Ratsch IM, Fabiani E, Rossini M, Bordicchia F, Coppa GV, Giorgi PL: Coeliac disease in the year 2000: exploring the iceberg. Lancet 343:200–203, 1994
Not T, Horvath K, Hill ID, Partanen J, Hammed A, Magazzu G, Fasano A: Celiac disease risk in the USA. High prevalence of antiendomysium antibodies in healthy blood donors. Scand J Gastroenterol 33:494–498, 1998
Moxley RT, Pozefsky T, Lockwood DH: Protein nutrition and liver disease after jejunoileal bypass for morbid obesity. N Engl J Med 290:921–926, 1974
Drenick EJ, Fisler J, Johnson D: Hepatic steatosis after intestinal bypass. Prevention and reversal by metronidazole irrespective of protein calorie nutrition. Gastroenterology 82:535–548, 1982
Van Steenbergen W, Lanckmans S: Liver disturbance in obesity and diabetes mellitus. Int J Obes 19(suppl 3):S27–S36, 1995
Creutzfeldt W, Frerichs H, Sickinger K: Liver disease and diabetes mellitus. Prog Liver Dis 3:371–407, 1970
Stone BG, Van Thiel DH: Diabetes mellitus and the liver. Semin Liver Dis 5:8–28, 1985
Henry RR, Wallace P, Olefsky JM: Effect of weight loss on mechanisms of hyperglycemia in obese non-insulin dependent diabetes mellitus. Diabetes 35:990–998, 1986
Bodardus C, Lillioja S, Howard BV, Reaven G, Mott D: Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin dependent diabetic subjects. J Clin Invest 74:1238–1246, 1984
Mavrellis PG, Ammon HV, Gleysteen JJ, Komorowski RA, Charaf UK: Hepatic free fatty acids in alcoholic liver disease and morbid obesity. Hepatology 3:26–231, 1983
Acosta D, Wenzel DG: Injury produced by free fatty acids to lysosomes and mitochondria in cultured heart muscle and endothelial cells. Atherosclerosis 20:417–426, 1974
Yang SO, Lin HZ, Lane MD, Clemens M. Diehl AM: Obesity increases sensitivity to endotoxin liver injury: Implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci USA 94:2557–2562, 1997
Day CP, James OFW: Steatohepatitis: A tale of two “hits”? Gastroenterology 114:842–845, 1998
Baeuerle PA, Henkel T: Function and activation of NF-κB in the immune system. Annu Rev Immunol 12:141–179, 1994
Lee KS, Buck M, Houglum K, Chojkier M: Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression. J Clin Invest 96:2461–2468, 1995
Bedosa P, Houglum K, Trautwein C, Hoslstege A, Chokjkier M: Stimulation of collagen alpha 1 (1) gene expression is associate with lipid peroxidation in hepatocellular injury: A link to tissue fibrosis. Hepatology 19:1262–1271, 1994
Letteron P, Fromenty B, Terris B, Degott C, Pessayra D: Acute and chronic hepatic steatosis lead to in vivo lipid peroxidation in mice. J Hepatol 24:200–208, 1996
Berson A, DeBeco V, Letterson P, Robin MA, Mareau C, El Kahwaji J, Verthier N, Feldman G, Fromenty B, Pessayre D: Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes. Gastroenterology 114:764–774, 1998
Zelman S: The liver in obesity. Arch Intern Med 90:141–156, 1952
Angulo P, Keach J, Batts KP, Lindor KD: Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 30:1356–1362, 1999
Zeisel SH: Dietary choline, biochemistry, physiology and pharmacology. Annu Rev Nutr 1:95–121, 1981
Sheard NF, Tayek JA, Bistrian BR, Blackburn GL, Zeisel SH: Plasma choline concentrations in humans fed parenterally. Am J Clin Nut 43:219–224, 1986
Buchman AL, Dubin M, Jenden D, Moukarzel A, Roch MH, Rice K, Gornbein J, Ament ME: Lecithin increases plasma Free choline and decreases hepatic steatosis in long term parenteral nutrition patients. Gastroenterology 102:1363–1370, 1992
Buchman AL, Dubin MD, Moukarzel A, Jenden DJ, Roch M, Rice KM, Gornbein J, Ament ME: Choline deficiency: A cause of hepatic steatosis during parenteral nutrition that can be reversed by intravenous choline supplementation. Hepatology 22:1399–1403, 1995
Hagander B, Berg NO, Brandt L, Norden A, Sjolund K, Stenstam M: Hepatic injury in adult coeliac disease. Lancet 2:270–272, 1977
Bardella MT, Fraquelli M, Quatrini M, Molteni N, Bianchi P, Conte D: Prevalence of hypertransaminasemia in adult celiac patients and effect of gluten free diet. Hepatology 22:833–836, 1995
Dickey W, McMillan SA, Collins JS, Watson RG, McLoughlin JC, Love AH: Liver abnormalities associated with celiac sprue. How common are they, what is their significance, and what do we do about them? J Clin Gastroenterol 20:290–292, 1995
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nehra, V., Angulo, P., Buchman, A.L. et al. Nutritional and Metabolic Considerations in the Etiology of Nonalcoholic Steatohepatitis. Dig Dis Sci 46, 2347–2352 (2001). https://doi.org/10.1023/A:1012338828418
Issue Date:
DOI: https://doi.org/10.1023/A:1012338828418